European Perspectives

Van Zyl Engelbrecht, Clinical Project Director in the EU - January 22, 2019
UBC’s Clinical Project Director in the EU, Van Zyl Engelbrecht, recently took part in a PharmaVOICE podcast on, “Successfully Managing & Implementing Orphan Drug Development Programs.” The presentation included the following...
Tagged in:
Leo Tysak, Executive Director, Global Regulatory Compliance - March 31, 2017
Much of my team’s day-to-day responsibilities come down to planning: planning for good quality assurance practices, planning in case of a regulatory inspection, planning responses to questions during an inspection, and even planning...
Named Patient Programme (NPP)
UBC - January 10, 2017
As regulatory review timelines grow, more patients are requesting access to medications in the window between a Phase III trial and marketing approval. Compassionate Use Programmes (CUPs) must balance urgency with eligibility and...
2017 pharmaceutical industry predictions
UBC - January 03, 2017
After weighing in on the biggest trends from the last year, we asked a few of our experts to predict the forces that would shape the industry in 2017. Optimizing the Value of Healthcare The focus of 2017 will be about realizing the...
2016 Trends in Pharma
UBC - December 13, 2016
If 2016 had an overriding theme it was one of instability. This sense of volatility manifested in a variety of ways from political clashes to Brexit, and the pharmaceutical industry was not immune. What remains constant is the...

Pages